Oxcarbamazepine Pharmaceutical API
Pharmaceutical Premium
Pharmaceutical API

Oxcarbamazepine

High-purity pharmaceutical grade Oxcarbamazepine API manufactured to meet stringent USP/EP specifications for anticonvulsant medication production. Our pharmaceutical-grade Oxcarbamazepine delivers exceptional quality and consistency for critical pharmaceutical applications.

  • USP/EP Compliant Grade
  • High Purity (>99.5%)
  • Antiepileptic Drug
  • GMP Certified Manufacturing
  • Reliable Supply Chain
  • Complete Documentation
Request Quote Technical Support

Technical Specifications

Chemical Formula: C15H12N2O2
CAS Number: 28721-07-5
EINECS Number: 249-274-8
Purity (HPLC): ≥99.5% (USP/EP Grade)
Physical State: White to off-white crystalline powder
Molecular Weight: 252.27 g/mol
Melting Point: 214-216°C
pH (1% solution): 6.0-8.0
Loss on Drying: ≤0.5%
Residue on Ignition: ≤0.1%
Heavy Metals: ≤10 ppm
Solubility: Practically insoluble in water
Storage Conditions: Store below 25°C, dry place
Shelf Life: 3 years from manufacture date
Packaging Options: 25kg, 50kg fiber drums

Applications

Antiepileptic Therapy
Seizure Control Medications
Tablet Formulations
Oral Suspension Preparations
Neurological Disorders
Extended Release Formulations
Bipolar Disorder Treatment
Mood Stabilization
Neurological Research
Drug Development
Pharmacological Studies
Clinical Trials

Industry-Specific Grades

DRAVYOM offers specialized Oxcarbamazepine grades tailored for specific neurological applications, ensuring optimal antiepileptic efficacy and regulatory compliance across diverse pharmaceutical formulations.

USP Grade (United States Pharmacopoeia)
Purity: ≥99.5% Water Content: ≤0.5% Heavy Metals: ≤10 ppm Application: FDA approved formulations
EP Grade (European Pharmacopoeia)
Purity: ≥99.5% Related Substances: ≤0.5% Residual Solvents: EP limits Application: European market compliance
Research Grade
Purity: ≥98.0% Activity: Verified Stability: Enhanced Application: Neurological research
Extended Release Grade
Purity: ≥99.5% Particle Size: Controlled Flow Properties: Optimized Application: SR formulations

Quality Standards

DRAVYOM's Oxcarbamazepine is manufactured under stringent cGMP protocols, meeting international neurological drug standards including USP, EP, and FDA guidelines for antiepileptic applications.

cGMP Manufacturing Standards
USP/EP Grade Specifications
≥99.5% HPLC Purity
Advanced Analytical Testing
Neurological Efficacy Verified
Batch-to-Batch Consistency
Comprehensive COA Documentation
Controlled Storage & Shipping

Advanced Chemical Properties & Performance

Pharmaceutical Grade Oxcarbamazepine exhibits exceptional chemical properties essential for neurological applications. Its potent anticonvulsant structure and superior stability characteristics ensure reliable performance in demanding antiepileptic formulations.

Molecular Properties
Molecular Weight: 252.27 g/mol
Molecular Formula: C15H12N2O2
LogP (Octanol/Water): 2.3
pKa: 2.3
Physical Properties
Melting Point: 215-220°C
Appearance: White to off-white crystalline powder
Solubility (Water): 7.7 mg/L at 25°C
Bulk Density: 0.45-0.55 g/cm³
Pharmaceutical Properties
Bioavailability: 96%
Protein Binding: 40%
Half-life: 2-11 hours
Mechanism: Sodium channel blockade
Quality Specifications
Purity (HPLC): ≥99.5%
Water Content: ≤0.5%
Related Substances: ≤0.5%
Heavy Metals: ≤10 ppm
Stability Properties
Shelf Life: 3 years (unopened)
Storage Temperature: 15-25°C
Light Sensitivity: Store in light-resistant containers
Moisture Sensitivity: Store in dry conditions

Performance Characteristics

Detailed performance metrics demonstrate Oxcarbamazepine superiority in neurological applications with exceptional sodium channel blockade, seizure control, and therapeutic efficacy across diverse epilepsy treatment protocols.

Sodium Channel Blockade

Selective voltage-gated sodium channel inhibition

Effective seizure prevention
Seizure Control

Broad-spectrum antiepileptic activity

Superior therapeutic outcomes
Extended Action

Long-lasting anticonvulsant effects

Sustained seizure control
Mood Stabilization

Additional mood stabilizing properties

Dual therapeutic benefits
Clinical Efficacy

FDA-approved for epilepsy treatment

Proven neurological benefits
Formulation Stability

Stable across various dosage forms

Versatile pharmaceutical applications

Safety Information

Pharmaceutical active ingredient requiring careful handling protocols. Handle in controlled environments with appropriate ventilation systems. Use proper personal protective equipment and follow established safety protocols for antiepileptic compounds.

Neurological Active
Controlled Handling Required
Specialized PPE Required

Storage & Handling

Store in tightly closed, light-resistant containers in a cool, dry place away from direct sunlight. Maintain controlled room temperature storage and ensure protection from moisture and humidity to preserve pharmaceutical quality and neurological potency.

Controlled room temperature (15-25°C)
Protect from light
Light-resistant containers
Store in dry conditions

Chemical Mechanisms & Reaction Pathways

Oxcarbamazepine functions as an anticonvulsant through sodium channel blockade and calcium channel modulation, providing effective seizure control with improved tolerability compared to traditional anticonvulsants.

Sodium Channel Block

Voltage-gated sodium channel inhibition

Seizure prevention and control
Active Metabolite

Conversion to 10-hydroxy metabolite (MHD)

Primary therapeutic activity
Calcium Modulation

Calcium channel activity modification

Additional anticonvulsant mechanism
Pharmacokinetic Profile

Excellent oral bioavailability with predictable kinetics

Reliable therapeutic dosing

Regulatory Compliance & Documentation

Comprehensive regulatory compliance ensures global pharmaceutical acceptance with complete documentation packages supporting international drug development and manufacturing requirements.

USP Specifications

United States Pharmacopeia pharmaceutical grade compliance

EP Standards

European Pharmacopoeia specifications and testing protocols

ICH Guidelines

International harmonized pharmaceutical development standards

Global Regulatory

Multi-regional pharmaceutical registration support

DMF Support

Drug Master File preparation and regulatory submission

GMP Compliance

Good Manufacturing Practice certified production

Technical Support & Value-Added Services

DRAVYOM's pharmaceutical development team provides comprehensive formulation support, analytical method development, and regulatory assistance to optimize Oxcarbamazepine performance in pharmaceutical applications.

Formulation Development
  • Tablet formulation optimization
  • Oral suspension development
  • Extended-release formulations
  • Stability enhancement strategies
Analytical Services
  • Method validation and transfer
  • Impurity profiling and identification
  • Stability testing programs
  • Dissolution testing support
Regulatory Support
  • Regulatory strategy development
  • Documentation preparation
  • Regulatory submission support
  • Global compliance guidance
Supply Solutions
  • Reliable supply chain management
  • Flexible packaging options
  • Emergency supply arrangements
  • Global distribution network

Environmental Impact & Sustainability

Our Oxcarbamazepine production emphasizes environmental responsibility through sustainable pharmaceutical manufacturing practices, waste minimization, and comprehensive environmental impact management.

Green Chemistry

Environmentally conscious synthesis with minimal waste

Water Management

Advanced wastewater treatment and recycling systems

Energy Efficiency

Optimized manufacturing processes with reduced energy consumption

Waste Reduction

Comprehensive waste minimization and disposal protocols

ISO 14001

Environmental management system certified production

Carbon Footprint

Reduced environmental impact through sustainable practices

Manufacturing Excellence & Quality Control

DRAVYOM's state-of-the-art pharmaceutical manufacturing facility employs advanced synthesis technology and continuous monitoring systems to ensure consistent Oxcarbamazepine quality and performance across all production batches.

GMP Production

Good Manufacturing Practice certified facility with controlled environments

Pharmaceutical-grade production standards
Quality Testing

Comprehensive analytical testing including potency and purity

HPLC, LC-MS, and pharmacopeial methods
Quality Systems

ISO 9001:2015 quality management with pharmaceutical compliance

Continuous improvement and validation protocols
Packaging Control

Controlled atmosphere packaging with moisture protection

Stability maintenance and protection systems

Market Applications & Performance Data

Comprehensive pharmaceutical data demonstrating Oxcarbamazepine effectiveness across diverse therapeutic applications with quantified performance metrics and clinical validation.

Pharmaceutical Manufacturing
Bioavailability: >95% oral absorption Stability: 3+ years shelf life Purity: >99.5% pharmaceutical grade
Drug Development
Formulation Support: Anticonvulsant products Regulatory Success: Global approvals achieved Innovation: Extended-release formulations
Clinical Applications
Efficacy: Superior seizure control Safety: Improved tolerability profile Versatility: Multiple epilepsy types

DRAVYOM Competitive Advantages

Pharmaceutical Excellence

Consistently exceeds USP/EP specifications with pharmaceutical-grade quality and performance

Reliable Supply

Guaranteed availability with strategic inventory management and pharmaceutical-grade production

Development Expertise

Dedicated pharmaceutical team provides formulation development and regulatory support

Quality Assurance

Comprehensive documentation with pharmaceutical-grade certificates and regulatory compliance

Global Standards

International compliance with USP, EP, and ICH guidelines for worldwide acceptance

Partnership Approach

Collaborative relationships with pharmaceutical companies and custom development services